Hyperandrogenemia in patients presenting with acne

Scott M. Slayden, Carlos Moran, W. Mitchell Sams, Larry R. Boots, Ricardo Azziz

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objective: To determine whether acne is associated with hyperandrogenemia, regardless of age of presentation. Design: Prospective controlled study.Setting: Tertiary-care medical center. Patient(s): Thirty consecutive unselected women presenting with acne and no hirsutism and 24 eumenorrheic healthy controls. Intervention(s): Serum samples was taken in all patients, and an acute 60-minute ACTH-(1-24) test was performed in 19 patients. Main Outcome Measure(s): Total and free T, sex hormone-binding globulin (SHBG), and DHEAS levels in basal samples, and ACTH-stimulated 17-hydroxyprogesterone (17-HP) response to exclude 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) were determined. Result(s): Nonhirsute patients with acne demonstrated significantly lower levels of SHBG and higher free-T and DHEAS levels than controls. Nineteen (63%) acneic patients had at least one androgen value above the 95% of controls. In patients aged 12-18 years, 7/8 (88%) had at least one increased androgen value, compared with 12/22 (55%) patients aged 19-43 years. One patient (5.3%) was found to have 21-OH-deficient NCAH. Conclusion(s): Hyperandrogenemia was evident in a majority of nonhirsute acneic patients studied, regardless of age. These data suggest that androgen suppression may be useful in treating acne in many of these patients.

Original languageEnglish (US)
Pages (from-to)889-892
Number of pages4
JournalFertility and Sterility
Volume75
Issue number5
DOIs
StatePublished - May 15 2001

Fingerprint

Acne Vulgaris
Androgens
Sex Hormone-Binding Globulin
Hyperplasia
Cosyntropin
17-alpha-Hydroxyprogesterone
Steroid 21-Hydroxylase
Hirsutism
Tertiary Care Centers
Adrenocorticotropic Hormone
Outcome Assessment (Health Care)
Prospective Studies

Keywords

  • ACTH
  • Acne
  • Adrenal hyperplasia
  • Androgens

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Slayden, S. M., Moran, C., Sams, W. M., Boots, L. R., & Azziz, R. (2001). Hyperandrogenemia in patients presenting with acne. Fertility and Sterility, 75(5), 889-892. https://doi.org/10.1016/S0015-0282(01)01701-0

Hyperandrogenemia in patients presenting with acne. / Slayden, Scott M.; Moran, Carlos; Sams, W. Mitchell; Boots, Larry R.; Azziz, Ricardo.

In: Fertility and Sterility, Vol. 75, No. 5, 15.05.2001, p. 889-892.

Research output: Contribution to journalArticle

Slayden, SM, Moran, C, Sams, WM, Boots, LR & Azziz, R 2001, 'Hyperandrogenemia in patients presenting with acne', Fertility and Sterility, vol. 75, no. 5, pp. 889-892. https://doi.org/10.1016/S0015-0282(01)01701-0
Slayden SM, Moran C, Sams WM, Boots LR, Azziz R. Hyperandrogenemia in patients presenting with acne. Fertility and Sterility. 2001 May 15;75(5):889-892. https://doi.org/10.1016/S0015-0282(01)01701-0
Slayden, Scott M. ; Moran, Carlos ; Sams, W. Mitchell ; Boots, Larry R. ; Azziz, Ricardo. / Hyperandrogenemia in patients presenting with acne. In: Fertility and Sterility. 2001 ; Vol. 75, No. 5. pp. 889-892.
@article{82eb5edf78a143e6a02d7602144f730c,
title = "Hyperandrogenemia in patients presenting with acne",
abstract = "Objective: To determine whether acne is associated with hyperandrogenemia, regardless of age of presentation. Design: Prospective controlled study.Setting: Tertiary-care medical center. Patient(s): Thirty consecutive unselected women presenting with acne and no hirsutism and 24 eumenorrheic healthy controls. Intervention(s): Serum samples was taken in all patients, and an acute 60-minute ACTH-(1-24) test was performed in 19 patients. Main Outcome Measure(s): Total and free T, sex hormone-binding globulin (SHBG), and DHEAS levels in basal samples, and ACTH-stimulated 17-hydroxyprogesterone (17-HP) response to exclude 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) were determined. Result(s): Nonhirsute patients with acne demonstrated significantly lower levels of SHBG and higher free-T and DHEAS levels than controls. Nineteen (63{\%}) acneic patients had at least one androgen value above the 95{\%} of controls. In patients aged 12-18 years, 7/8 (88{\%}) had at least one increased androgen value, compared with 12/22 (55{\%}) patients aged 19-43 years. One patient (5.3{\%}) was found to have 21-OH-deficient NCAH. Conclusion(s): Hyperandrogenemia was evident in a majority of nonhirsute acneic patients studied, regardless of age. These data suggest that androgen suppression may be useful in treating acne in many of these patients.",
keywords = "ACTH, Acne, Adrenal hyperplasia, Androgens",
author = "Slayden, {Scott M.} and Carlos Moran and Sams, {W. Mitchell} and Boots, {Larry R.} and Ricardo Azziz",
year = "2001",
month = "5",
day = "15",
doi = "10.1016/S0015-0282(01)01701-0",
language = "English (US)",
volume = "75",
pages = "889--892",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Hyperandrogenemia in patients presenting with acne

AU - Slayden, Scott M.

AU - Moran, Carlos

AU - Sams, W. Mitchell

AU - Boots, Larry R.

AU - Azziz, Ricardo

PY - 2001/5/15

Y1 - 2001/5/15

N2 - Objective: To determine whether acne is associated with hyperandrogenemia, regardless of age of presentation. Design: Prospective controlled study.Setting: Tertiary-care medical center. Patient(s): Thirty consecutive unselected women presenting with acne and no hirsutism and 24 eumenorrheic healthy controls. Intervention(s): Serum samples was taken in all patients, and an acute 60-minute ACTH-(1-24) test was performed in 19 patients. Main Outcome Measure(s): Total and free T, sex hormone-binding globulin (SHBG), and DHEAS levels in basal samples, and ACTH-stimulated 17-hydroxyprogesterone (17-HP) response to exclude 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) were determined. Result(s): Nonhirsute patients with acne demonstrated significantly lower levels of SHBG and higher free-T and DHEAS levels than controls. Nineteen (63%) acneic patients had at least one androgen value above the 95% of controls. In patients aged 12-18 years, 7/8 (88%) had at least one increased androgen value, compared with 12/22 (55%) patients aged 19-43 years. One patient (5.3%) was found to have 21-OH-deficient NCAH. Conclusion(s): Hyperandrogenemia was evident in a majority of nonhirsute acneic patients studied, regardless of age. These data suggest that androgen suppression may be useful in treating acne in many of these patients.

AB - Objective: To determine whether acne is associated with hyperandrogenemia, regardless of age of presentation. Design: Prospective controlled study.Setting: Tertiary-care medical center. Patient(s): Thirty consecutive unselected women presenting with acne and no hirsutism and 24 eumenorrheic healthy controls. Intervention(s): Serum samples was taken in all patients, and an acute 60-minute ACTH-(1-24) test was performed in 19 patients. Main Outcome Measure(s): Total and free T, sex hormone-binding globulin (SHBG), and DHEAS levels in basal samples, and ACTH-stimulated 17-hydroxyprogesterone (17-HP) response to exclude 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) were determined. Result(s): Nonhirsute patients with acne demonstrated significantly lower levels of SHBG and higher free-T and DHEAS levels than controls. Nineteen (63%) acneic patients had at least one androgen value above the 95% of controls. In patients aged 12-18 years, 7/8 (88%) had at least one increased androgen value, compared with 12/22 (55%) patients aged 19-43 years. One patient (5.3%) was found to have 21-OH-deficient NCAH. Conclusion(s): Hyperandrogenemia was evident in a majority of nonhirsute acneic patients studied, regardless of age. These data suggest that androgen suppression may be useful in treating acne in many of these patients.

KW - ACTH

KW - Acne

KW - Adrenal hyperplasia

KW - Androgens

UR - http://www.scopus.com/inward/record.url?scp=0035032740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035032740&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(01)01701-0

DO - 10.1016/S0015-0282(01)01701-0

M3 - Article

VL - 75

SP - 889

EP - 892

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -